- Home
- HKPD vs PIII Comparison
HKPD vs PIII Comparison
Compare HKPD & PIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HKPD | PIII |
|---|---|---|
| Founded | 2016 | 2015 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.6M | 10.8M |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | HKPD | PIII |
|---|---|---|
| Price | $0.80 | $2.14 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $16.25 |
| AVG Volume (30 Days) | 50.7K | ★ 120.0K |
| Earning Date | 08-14-2026 | 03-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $20,313,818.00 | ★ $1,444,952,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $14.85 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 21.72 | N/A |
| 52 Week Low | $0.66 | $1.52 |
| 52 Week High | $2.76 | $12.45 |
Technical Indicators
Market Signals| Indicator | HKPD | PIII |
|---|---|---|
| Relative Strength Index (RSI) | 47.38 | 40.67 |
| Support Level | $0.75 | $1.92 |
| Resistance Level | $0.89 | $2.85 |
| Average True Range (ATR) | 0.08 | 0.42 |
| MACD | -0.00 | 0.09 |
| Stochastic Oscillator | 57.90 | 46.62 |
Price Performance
Historical ComparisonAbout HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.
About PIII P3 Health Partners Inc.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.